BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
SIRT1
,
Metabolism of xenobiotics
,
Allergy to pollen
,
Retina
,
Anticancer prodrugs
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
azimilide
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Inhibitory effect of azimilide on Na+/Ca2+ exchange current in guinea-pig cardiac myocytes.
Azimilide reduces emergency department visits and hospitalizations in patients with an implantable c…
Azimilide for the treatment of atrial fibrillation, atrial flutter, and paroxysmal supraventricular …
The impact of acute myocardial ischemia on the ventricular defibrillation threshold during chronic o…
Azimilide: another effort to prevent implantable cardioverter-defibrillator shocks and their sequela…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effect of Azimilide Dihydrochloride on Renal Function
Efficacy and Safety of Azimilide in the Prophylactic Treatment of Patients With Atrial Fibrillation.
Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverte…
Efficacy and Safety of Azimilide for the Treatment of Patients With Atrial Fibrillation
Long Term Safety of 125 mg Per Day of Oral Azimilide in Patients With Implantable Cardioverter Defib…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ